6 Firms Build Canadian Biotech SPAC Merger
EnGene Inc., a Canadian clinical-stage biotechnology company, on Wednesday announced that it will go public through a merger with Netherlands-headquartered special purpose acquisition company Forbian European Acquisition Corp. in a deal...To view the full article, register now.
Already a subscriber? Click here to view full article